Clinical Trial Update: To Evaluate the Efficacy and the Safety of Monthly Versus Weekly Oral Risedronate With Vitamin D in Compliance, Improvement of Vitamin D and BMD in Korean Postmenopausal Osteoporotic Women [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating monthly versus weekly oral risedronate with vitamin D for adherence, vitamin D levels, and bone mineral density in Korean postmenopausa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Vitamin D (Cholecalciferol)
• risedronate (risedronate)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED